Weekly: Crescita Therapeutics tumbles 16.1% on weak volume September 21, 2018 17:00 EDT
CANADIAN WEEKLY STOCK REPORT
Crescita Therapeutics Inc. (TSX:CTX), Canada's 43rd largest Biotechnology company by market cap, has sunk 9.0c (or 16.1%) in the past week to close at 47.0c. Compared with the S&P/TSX 60 Index which rose 14.9 points (or 1.6%) in the week, this represented a relative price change of -17.5%. The volume was 0.5 times average trading per week of 173,415 shares. In the past week the market cap has slumped CAD1.9 million (US$1.5 million).